159 related articles for article (PubMed ID: 16416745)
1. Cold-dependent loss of factor VIII von Willebrand factor activities in citrated whole blood is reversed by rewarming.
Refaai MA; Lukoszyk M; Hughes J; Eby CS; Van Cott EM
Am J Clin Pathol; 2005 Dec; 124(6):972; author reply 973. PubMed ID: 16416745
[No Abstract] [Full Text] [Related]
2. Loss of factor VIII and von Willebrand factor activities during cold storage of whole blood is reversed by rewarming.
Refaai MA; Van Cott EM; Lukoszyk M; Hughes J; Eby CS
Lab Hematol; 2006; 12(2):99-102. PubMed ID: 16751138
[TBL] [Abstract][Full Text] [Related]
3. Cold storage of citrated whole blood induces drastic time-dependent losses in factor VIII and von Willebrand factor: potential for misdiagnosis of haemophilia and von Willebrand disease.
Böhm M; Täschner S; Kretzschmar E; Gerlach R; Favaloro EJ; Scharrer I
Blood Coagul Fibrinolysis; 2006 Jan; 17(1):39-45. PubMed ID: 16607078
[TBL] [Abstract][Full Text] [Related]
4. [Stability of ristocetin cofactor and factor VIII associated antigen in relation to storage conditions].
Töpfer G; Lutze G; Schmidt LH; Friedel G; Seifert A; Novy EM; Lehmann L
Z Med Lab Diagn; 1983; 24(8):463-8. PubMed ID: 6424351
[No Abstract] [Full Text] [Related]
5. Stability of von Willebrand factor in blood stored at 4 degrees C.
Hondow JA; Russell WJ; Tunbridge LJ; Lloyd JV
Thromb Res; 1982 Jul; 27(2):125-30. PubMed ID: 6814001
[No Abstract] [Full Text] [Related]
6. Changes in factor VIII complex activities during the production of a clinical intermediate purity factor VIII concentrate.
Prowse CV; Griffin B; Pepper DS; Dickson AJ; McQuillan TA; Dickson IH; Foster PR
Thromb Haemost; 1981 Oct; 46(3):597-601. PubMed ID: 6797090
[TBL] [Abstract][Full Text] [Related]
7. Improved blood preservation with 0.5CPD erythro-sol. Coagulation factor VIII activity and erythrocyte quality after delayed separation of blood.
Solheim BG; Bergerud UE; Kjeldsen-Kragh J; Brosstad F; Mollnes TE; Högman CF; Eriksson L; Schutz R
Vox Sang; 1998; 74(3):168-75. PubMed ID: 9595644
[TBL] [Abstract][Full Text] [Related]
8. Effect of overnight 4 degrees C storage of whole blood on von Willebrand factor.
Favaloro EJ
Transfusion; 2006 Jun; 46(6):1057-9; author reply 1059-60. PubMed ID: 16734825
[No Abstract] [Full Text] [Related]
9. Plasma levels of von Willebrand factor, von Willebrand factor propeptide and factor VIII in carriers and patients with nephrogenic diabetes insipidus.
Nossent AY; Ellenbroek JH; Frölich M; Bertina RM; Knoers NV; Eikenboom JC
Thromb Res; 2010 Jun; 125(6):554-6. PubMed ID: 20430418
[No Abstract] [Full Text] [Related]
10. [Studies on the dynamics of plasma factor VIII/von Willebrand factor activity in cerebrovascular diseases].
Shinmyozu K; Maruyama Y; Ohkatsu Y; Maruyama I; Igata A
Rinsho Shinkeigaku; 1983 Feb; 23(2):172-9. PubMed ID: 6407797
[No Abstract] [Full Text] [Related]
11. Stability of canine factor VIII activity and von Willebrand factor antigen concentration in vitro.
Mansell PD; Parry BW
Res Vet Sci; 1991 Nov; 51(3):313-6. PubMed ID: 1780587
[TBL] [Abstract][Full Text] [Related]
12. Factor VIII/von Willebrand factor levels in plasma frozen to-30 degrees C in air or halogenated hydrocarbons.
Farrugia A; Hill R; Douglas S; Karabagias K; Kleinig A
Thromb Res; 1992 Oct; 68(1):97-102. PubMed ID: 1448801
[No Abstract] [Full Text] [Related]
13. The in vitro association of antihemophilic factor and von Willebrand factor.
Zucker MB; Soberano ME; Johnson AJ; Fulton AJ; Kowalski S; Adler M
Thromb Haemost; 1983 Feb; 49(1):37-41. PubMed ID: 6405497
[No Abstract] [Full Text] [Related]
14. Abnormal plasma levels of factor VIII/von Willebrand factor complex in myocardial infarction--expression of acute phase reaction or index of vascular endothelium damage?
Giustolisi R; Musso R; Cacciola E; Cacciola RR; Russo M; Petralito A
Thromb Haemost; 1984 Jul; 51(3):408. PubMed ID: 6437008
[No Abstract] [Full Text] [Related]
15. Comparative analysis and classification of von Willebrand factor/factor VIII concentrates: impact on treatment of patients with von Willebrand disease.
Budde U; Metzner HJ; Müller HG
Semin Thromb Hemost; 2006 Sep; 32(6):626-35. PubMed ID: 16977573
[TBL] [Abstract][Full Text] [Related]
16. Managing patients with von Willebrand disease type 1, 2 and 3 with desmopressin and von Willebrand factor-factor VIII concentrate in surgical settings.
Michiels JJ; van Vliet HH; Berneman Z; Schroyens W; Gadisseur A
Acta Haematol; 2009; 121(2-3):167-76. PubMed ID: 19506363
[TBL] [Abstract][Full Text] [Related]
17. Characterization of microvasculature in the stroma of human colorectal carcinoma: an immunoelectron microscopic study on factor VIII/von Willebrand factor.
Ohtani H; Sasano N
J Electron Microsc (Tokyo); 1987; 36(4):204-12. PubMed ID: 3121775
[No Abstract] [Full Text] [Related]
18. [Acquired von Willebrand factor abnormalities in chronic myeloproliferative disorders].
Tatewaki W; Takahashi H; Shibata A
Rinsho Byori; 1989 Apr; Spec No 81():41-5. PubMed ID: 2502642
[No Abstract] [Full Text] [Related]
19. [Stimulation of the release of factor VIII and von Willebrand factor into the plasma of donors and the cryoprecipitate].
Elykomov VA; Tsalikhin AD; Barkagan ZS
Gematol Transfuziol; 1993 Feb; 38(2):40-1. PubMed ID: 8020721
[No Abstract] [Full Text] [Related]
20. Properties of a concentrated minipool solvent-detergent treated cryoprecipitate processed in single-use bag systems.
Burnouf T; Caron C; Radosevich M; Goubran HA; Goudemand J; El-Ekiaby M
Haemophilia; 2008 Sep; 14(5):956-62. PubMed ID: 18565126
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
